Document is current

Article History

Received: 24 October 2022

Accepted: 30 April 2023

First Online: 10 May 2023

Declarations

:

: All methods in the study adhered to the Tri-Council Policy Statement: Ethical Conduct of Research Involving Humans (TCPS 2) and followed the code of ethics and practices established by the American Association of Public Opinion Research (AAPOR), which addresses ethical considerations for survey researchers (). The procedures used in this study adhere to the tenets of the Declaration of Helsinki. The reporting of the survey followed the Checklist for Reporting Results of Internet E-Survey (CHERRIES) – a set of reporting recommendations designed to ensure the quality of Internet-based research (). This study and the research activities conducted as part of this study were exempt from review by a Research Ethics Board based on the following: (1) this research qualified under “quality assurance/quality improvement (QA/QI) studies, program evaluation activities, and performance reviews, or testing within normal educational and/or organizational requirements, to be used for assessment, management, and/or improvement purposes” (TCPS 2 Articles 2.2–2.5); (2) this research involved the secondary use of data that were provided without any direct identifier or group of identifiers that would allow the attribution of private information to an individual (TCPS 2 Article 5.5); (3) this research constituted reflective practice/professional development activity that involved others (e.g., colleagues, students, and supervisors) to solicit information that could be used for self-evaluation and growth, provided no information about these other individuals was made public or identifiable. This study involved the informed consent process, which was compliant with the AAPOR code of ethics and practices for survey research. This study and the research activities conducted as part of this study were exempt from obtaining a written informed consent signature from participants as this research involved the secondary use of data that were provided without any direct identifier or group of identifiers that would allow the attribution of private information to an individual (TCPS 2 Article 5.5). In addition, this study was non-intrusive and did not involve direct interaction between the researcher and individuals through the Internet. No administrative permissions were required to access the raw data, as the researchers who collected the data had ownership of the raw dataset, and the data were stored on local servers at the site of a Principal Investigator (Interventional Psychiatry Program, St. Michael’s Hospital, Toronto, Ontario, Canada). The data used in the study were collected from anonymous respondents, and direct identifiers were never collected, which makes it impossible to attribute the collected survey responses to particular individuals. This ethics framework has also been followed in a previously published manuscript derived from the same set of research and data collection activities ().

: Not applicable.

: ID, VKT, SD, AB, SL, MA, KF, JR, AV, and DK do not have any disclosures. In the last 5 years, ZJD has received research and equipment in-kind support for an investigator-initiated study through Brainsway Inc. and Magventure Inc. His work is supported by the Canadian Institutes of Health Research (CIHR), the National Institutes of Mental Health (NIMH), Brain Canada, and the Temerty Family and Grant Family through the Centre for Addiction and Mental Health (CAMH) Foundation and the Campbell Family Mental Health Research Institute. KK is supported in part by Merit Awards from the Department of Anesthesiology and Pain Medicine, University of Toronto, and has received support from Octapharma, Instrumentation Laboratory, and Bayer. SHK has received honoraria or research funds from Abbott, Alkermes, Allergan, Boehringer Ingelheim, Brain Canada, CIHR, Janssen, Lundbeck, Lundbeck Institute, Ontario Brain Institute, Ontario Research Fund, Otsuka, Pfizer, Servier, Sunovion, Sun Pharmaceuticals, and holds stock in Field Trip Health. KSL is supported in part by Merit Awards from the Department of Anesthesiology and Pain Medicine at the University of Toronto. SVP has received research support from the CIHR, Ontario Brain Institute, the Flinn Foundation, Sage, Takeda, and Assurex (Myriad); is a consultant to Assurex, Aifred, Mensante, Sage, Takeda, Janssen, and Otsuka; and has equity in Mensante. DMB has received research support from the CIHR, National Institutes of Health (NIH), Brain Canada, and the Temerty Family through the CAMH Foundation and the Campbell Family Mental Health Research Institute. He received research support and in-kind equipment support for an investigator-initiated study from Brainsway Ltd., and he is the principal site investigator for three sponsor-initiated studies for Brainsway Ltd. He receives in-kind equipment support from Magventure for investigator-initiated research. He received medication supplies for an investigator-initiated trial from Indivior. AJF has received grant support from the NIH, Patient-Centred Outcomes Research Institute, CIHR, Brain Canada, Ontario Brain Institute, Alzheimer’s Association, and AGE-WELL. VB is supported by an Academic Scholar Award from the Department of Psychiatry at the University of Toronto, and has received research support from CIHR, Brain & Behavior Foundation, Ministry of Health (MOH) Innovation Funds, The Royal College of Physicians and Surgeons of Canada (RCPSC), Department of National Defence (Government of Canada), and from Roche Canada for an investigator-initiated trial.